Details for New Drug Application (NDA): 050616
✉ Email this page to a colleague
The generic ingredient in TOBRADEX is dexamethasone; tobramycin. There are thirty-nine drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the dexamethasone; tobramycin profile page.
Summary for 050616
Tradename: | TOBRADEX |
Applicant: | Novartis |
Ingredient: | dexamethasone; tobramycin |
Patents: | 0 |
Pharmacology for NDA: 050616
Mechanism of Action | Corticosteroid Hormone Receptor Agonists |
Suppliers and Packaging for NDA: 050616
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
TOBRADEX | dexamethasone; tobramycin | OINTMENT;OPHTHALMIC | 050616 | NDA | Novartis Pharmaceuticals Corporation | 0078-0876 | 0078-0876-01 | 3.5 g in 1 TUBE (0078-0876-01) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | OINTMENT;OPHTHALMIC | Strength | 0.1%;0.3% | ||||
Approval Date: | Sep 28, 1988 | TE: | RLD: | Yes |
Expired US Patents for NDA 050616
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Novartis | TOBRADEX | dexamethasone; tobramycin | OINTMENT;OPHTHALMIC | 050616-001 | Sep 28, 1988 | ⤷ Subscribe | ⤷ Subscribe |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription